Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mack, G. FDA holds court on post hoc data linking KRAS status to drug response. Nat Biotechnol 27, 110–112 (2009). https://doi.org/10.1038/nbt0209-110c
Issue Date:
DOI: https://doi.org/10.1038/nbt0209-110c
- Springer Nature America, Inc.
This article is cited by
-
Predictive biomarkers: a paradigm shift towards personalized cancer medicine
Nature Reviews Clinical Oncology (2011)
-
Developing Pharmacogenetic Evidence Throughout Clinical Development
Clinical Pharmacology & Therapeutics (2010)